Form4insider filings, from the source

SEC Form 3 · accession 0001209191-15-047638

SOLENO THERAPEUTICS INC · SLNO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kristen Yen
Officer — See Remarks
Period of report
May 15, 2015
Accepted (ET)
May 28, 2015 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
No securities beneficially ownedholding———0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock OptionF1,F4,F5,F6,F7$10.56holding———Apr 3, 2007Jun 8, 2016Common Stock1,041—D
Employee Stock OptionF1,F4,F5,F6,F7$10.56holding———Mar 11, 2008Mar 14, 2017Common Stock520—D
Employee Stock OptionF2,F4,F5,F6,F7$3.48holding———Aug 15, 2007Sep 25, 2018Common Stock3,333—D
Employee Stock OptionF2,F4,F5,F6,F7$3.48holding———Nov 15, 2008Oct 15, 2018Common Stock3,437—D
Employee Stock OptionF2,F4,F5,F6,F7$1.20holding———Jul 1, 2010Jun 3, 2020Common Stock4,166—D
Employee Stock OptionF3,F4,F5,F6,F7$7.139holding———Nov 12, 2014Nov 12, 2024Common Stock52,389—D
Employee Stock OptionF1,F4,F5,F6,F7$1.80holding———Jan 11, 2016Jan 11, 2025Common Stock10,000—D
Employee Stock OptionF3,F4,F5,F6,F7$1.80holding———Jan 11, 2015Jan 11, 2025Common Stock13,097—D

Explanation of responses

Remarks

Vice President, Clinical and Regulatory